Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Non-Current Deffered Revenue (2015 - 2018)

Lemaitre Vascular (LMAT) reported Non-Current Deffered Revenue of $530000.0 for Q4 2018, down 5.53% year-over-year from $561000.0 in Q4 2017, and down 1.67% on a QoQ basis from $539000.0 in Q3 2018.

Lemaitre Vascular (LMAT) has 4 years of Non-Current Deffered Revenue data on file, last reported at $530000.0 in Q4 2018.

  • Quarterly Non-Current Deffered Revenue fell 5.53% year-over-year to $530000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $530000.0 (down 5.53% YoY) and the FY2018 annual result came in at $530000.0, down 5.53% from the prior year.
  • Non-Current Deffered Revenue retreated to $530000.0 in Q4 2018 per LMAT's latest filing, from $539000.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $561000.0 in Q4 2017 and bottomed at $281000.0 in Q4 2015.
  • The 4-year median for Non-Current Deffered Revenue is $532000.0 (2017), against an average of $481400.0.
  • The widest annual swing landed in 2017, when Non-Current Deffered Revenue jumped 42.39%; it then declined 5.53% in 2018.
  • Tracing LMAT's Non-Current Deffered Revenue over 4 years: stood at $281000.0 in 2015, then jumped by 40.21% to $394000.0 in 2016, then surged by 42.39% to $561000.0 in 2017, then fell by 5.53% to $530000.0 in 2018.
  • Per Business Quant, the three latest LMAT Non-Current Deffered Revenue figures stand at $530000.0 (Q4 2018), $539000.0 (Q3 2018), and $547000.0 (Q2 2018).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 163.15 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 11.80 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 206.40 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Lemaitre Vascular 2.28 Bn 1.91 Bn 48.40 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 530,000.00
Sep 30, 2018 539,000.00
Jun 30, 2018 547,000.00
Mar 31, 2018 554,000.00
Dec 31, 2017 561,000.00
Sep 30, 2017 534,000.00
Jun 30, 2017 452,000.00
Mar 31, 2017 422,000.00
Dec 31, 2016 394,000.00
Dec 31, 2015 281,000.00